Urapidil Base is a white crystalline powder. When dissolved, it forms a clear, colorless solution that is free of particles.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Deferasirox, marketed under the brand Refarmed Chemicals, is a cornerstone in the treatment of chronic iron overload due to blood transfusions in conditions such as thalassemia and sickle cell disease. This condition, if not properly managed, can have severe consequences for organ function. Deferasirox is available in oral tablet form, with strengths of 250 mg, 500 mg, and 1000 mg, allowing for flexibility and precision in dosing to meet individual patient needs. Crafted as an iron chelator, Deferasirox plays a crucial role in binding excess iron within the body and facilitating its excretion through urine. This targeted mechanism asserts its importance in maintaining a healthy balance of iron and preventing the potential toxicity associated with overload. Patients are advised to take Deferasirox with or without food, adhering to a dosing schedule that is tailored to their specific iron levels and bodily response, underscoring the need for a personalized approach to treatment. Regarding its physical properties, Deferasirox appears as a white to pale yellowish crystalline powder, primarily soluble in DMF (Dimethylformamide) and slightly soluble in methanol. These characteristics are essential for ensuring its effectiveness and stability as a pharmaceutical agent. It is imperative that patients undergo regular blood tests and health monitoring for optimum results and to prevent adverse effects such as gastrointestinal distress, skin reactions, and potential liver or renal impairment. Additionally, care must be taken in cases of known hypersensitivity to Deferasirox or pre-existing severe renal or liver conditions. Our documentation and certifications like Good Manufacturing Practice (GMP) and the Drug Master File (DMF) guarantee the highest levels of quality and compliance with industry standards. It is our priority to ensure that this crucial pharmaceutical material is of the utmost purity and efficacy, as reflected in our stringent quality control parameters including the presence of residual solvents and related substances, all documented for your assurance. Please note that while Deferasirox is a vital medication for many patients, it requires diligent medical supervision. Always consult healthcare professionals for specific medical advice and treatment instructions tailored to individual health profiles.

Products still subject to third-party patent protection might be available solely for R&D purposes.

**Product Overview: Febuxostat – A Robust Solution for Gout Management** Refarmed Chemicals presents Febuxostat, a meticulously prepared medication aimed at alleviating the pain and discomfort associated with gout. Made from a refined white powder, Febuxostat stands out in the pharmaceutical industry as a Xanthine Oxidase Inhibitor, crucial for managing hyperuricemia and recurrent gout attacks. Structured to meet corporate expectations, Febuxostat is a testament to Refarmed Chemicals' 30-year expertise in delivering quality generic and branded medications. Manufactured in compliance with strict guidelines, including the Drug Master File (DMF) and certifications such as WC and GMP, this product is a model of reliability and efficacy. Febuxostat's fundamental use is to decrease blood uric acid levels, offering those afflicted with gout a pathway to recovery by preventing acute flare-ups, and mitigating inflammation and pain in the joints. As a white, soluble powder, Febuxostat is highly soluble in DMSO and slightly soluble in methanol and water, simplifying its integration into diverse medical formulations. Clinical trials have informed a standard starting dosage of 40 mg, adjustable up to 80 mg based on individual patient requirements and the severity of symptoms. In its commitment to patient welfare, Refarmed Chemicals underlines potential side effects ranging from nausea and headaches to rashes, ensuring informed usage of Febuxostat. In alignment with our promise of transparency and safety, we advise consulting healthcare professionals for precise diagnotics and treatment plans. Furthermore, users should be attentive to contraindications, noting that Febuxostat is unsuitable for patients with severe liver or kidney disease, or for women who are pregnant or breastfeeding. Refarmed Chemicals' Febuxostat exceeds industry standards with its impressive assay value of 98.0% - 102.0% purity and a precise control of impurities, ensuring that the product meets stringent quality criteria. The company's analytical rigor is reflected in the detailed specification of residual solvents such as Acetone, Ethanol, and Isopropanol. In the journey to deliver improved health outcomes, Refarmed Chemicals' Febuxostat is more than just a medication; it symbolizes our dedication to quality, safety, and corporate responsibility in the global pharmaceutical landscape. [*Note: Product image depicts a detailed specification chart for Febuxostat, reiterating its quality and compositions.*]

Products still subject to third-party patent protection might be available solely for R&D purposes.

Pizotifen Maleate, presented by Refarmed Chemicals, is an instrumental pharmaceutical agent aiding in the management of several health conditions. Its primary use is in the prevention of migraines, a debilitating headache disorder known to impair the quality of life. Furthermore, it serves as a reliever for vestibular disorders, which include symptoms such as vertigo, dizziness, and tinnitus. In addition to these, Pizotifen Maleate has proven effective in treating pruritus, chronic itching skin conditions, and acts as an adjunctive therapy for asthma, providing relief from respiratory discomfort. Manufactured under stringent quality control conditions in India, Pizotifen is carefully crafted into tablets with dosages of 5 mg and 10 mg to accommodate varying therapeutic needs. The active ingredient is a histamine antagonist, functioning by obstructing histamine receptors in the body, hence mitigating inflammation and associated symptoms like itching. It is essential to note that while Pizotifen Maleate is generally well tolerated, common side effects might include drowsiness, dizziness, dry mouth, nausea, and occasional headaches. Due to its drowsing effects, this medication should be used cautiously, particularly when concentration is required, such as in driving or operating heavy machinery. Exercise caution before using Pizotifen Maleate if any of the following conditions are present: glaucoma, prostate enlargement, narrow-angle glaucoma, or any known hypersensitivity to the drug. Additionally, individuals with liver or kidney complications should consult their healthcare provider before commencing treatment. Stored ideally at room temperature, Pizotifen Maleate should be shielded from light and moisture. Full efficacy may take several weeks to establish, making it imperative to adhere to the prescribed dosage regime. In the occurrence of severe adverse effects, the treatment should be discontinued, and medical advice must be sought immediately. Each batch of Pizotifen Maleate undergoes rigorous testing ensuring a high purity—exemplified by the specifications pertaining to solubility, identification tests, and the stringent control over impurities. Your corporate clients can trust in the quality sustained by EU GMP certification, as reflected in the clear documentation and reliable manufacturing processes. Choosing Pizotifen is investing in a pharmaceutical product that is as dedicated to patient wellness as it is to consistent product integrity.

Products still subject to third-party patent protection might be available solely for R&D purposes.